Dr Lal Pathlabs Ltd share price logo

Dr Lal Share Price

NSE: LALPATHLAB

BSE: 539524

Small Cap

Healthcare Sector

1360.00

+20.80

(+1.55%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Dr Lal Stock Performance

as on March 6, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹1,332.50
    ₹1,366.90
    downward going graph

    2.02%

    Downside

    0.51%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹1,155.38
    ₹1,770.00
    downward going graph

    15.05%

    Downside

    30.15%

    Upside

    downward going graph

Dr Lal share price movements today

Previous Close
₹1,339.20
Open
₹1,338.90
Volume
2.73L
Upper Circuit
₹1,607.00
Lower Circuit
₹1,071.40
Day's Low - High
₹1,332.50 - ₹1,366.90
52 Week Low - High
₹1,155.38 - ₹1,770.00

Dr Lal Historical Returns

1 Month Return
-7.22 %
3 Month Return
-9.75 %
1 Year Return
+ 6.35 %
3 Year Return
+ 36.73 %
5 Year Return
+ 15.54 %

Dr Lal Fundamentals

as on March 6, 2026 at 4:01 pm IST

Market Cap

₹22,438.97 Cr

Return on Equity (ROE)

24.65

PE Ratio (TTM)

42.29

Return on capital employed (ROCE)

29.14

Industry PE ratio

47.65

Beta (LTM)

0.33

P/B Ratio

9.71

Dividend Yield

0.97

PEG Ratio

6.36

Quarterly Earnings Growth YOY

-6.83

EPS (TTM)

29.445

Sector

Healthcare

Book Value

129.96

Technical Analysis

Dr Lal Stock Valuation

as on March 6, 2026 at 4:01 pm IST

Dr Lal in the last 5 years

  • Overview

  • Trends

Lowest (37.51x)

November 16, 2018

Today (42.29x)

March 5, 2026

Industry (47.65x)

March 5, 2026

Highest (95.62x)

November 5, 2020

LowHigh

Today’s Price to Earnings Ratio: 42.29x

Dr Lal Pathlabs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dr Lal with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY22,438.973.11%0.544922,461
HOLD56,463.6041%0.713545,553
HOLD66,358.5819.85%0.592,21612,964
BUY9,878.0910.96%0.65143704
BUY5,963.134.9%0.5390687

Market expectation of Dr Lal Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

73.91%

Buy

4.35%

Hold

21.74%

Sell

Dr Lal Stock’s Investor Sentiment and Interest

Search interest for Dr Lal Pathlabs Ltd Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-14% versus previous 30 day period

Dr Lal Pathlabs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
491
541
601.3
538.9
545.4
601.9
660.2
596.7
602.6
669.8
730.6
659.8
Other Income
14.2
14.4
18.1
18.3
18.4
20.6
21.9
25.1
25.8
28.1
24.8
24.4
Total Income
505.2
555.4
619.4
557.2
563.8
622.5
682.1
621.8
628.4
697.9
755.4
684.2
Expenses
375.4
394.8
423.5
398.3
400.7
431.9
457.7
442.7
433.6
477.5
506.5
510.6
Operating Profit
115.6
146.2
177.8
140.6
144.7
170
202.5
154
169
192.3
224.1
149.2
Operating Profit Margin %
23.54%
27.02%
29.57%
26.09%
26.53%
28.24%
30.67%
25.81%
28.05%
28.71%
30.67%
22.61%
Profit Before Interest, Tax and Depreciation
129.8
160.6
195.9
158.9
163.1
190.6
224.4
179.1
194.8
220.4
248.9
173.6
Interest
9
8
7.8
7
6.6
6
6
5.3
5
4.7
4.8
7.2
Depreciation
37.6
35.1
35.9
36
36.6
34.7
35.3
35.5
36.4
34.6
40.5
42.1
Profit Before Tax
83.2
117.5
152.2
115.9
119.9
149.9
183.1
138.3
153.4
181.1
203.6
124.3
Tax Paid
26.3
33.9
41.5
33.7
34.1
42.1
52.3
40.2
-2.1
47.1
51.4
32.9
Profit After Tax
56.9
83.6
110.7
82.2
85.8
107.8
130.8
98.1
155.5
134
152.2
91.4
Total Net profit including share of profit / Loss from associate company
56.9
83.6
110.7
82.2
85.8
107.8
130.8
98.1
155.5
134
152.2
91.4
EPS
6.84
9.95
13.16
9.77
10.13
12.79
15.52
11.6
18.57
15.88
18.05
5.42
Actual EPS
6.84
9.95
13.16
9.77
10.13
12.79
15.52
11.6
18.57
15.88
18.05
5.42
Adjusted EPS
3.42
4.98
6.58
4.89
5.07
6.4
7.76
5.8
9.29
7.94
9.03
5.42
Diluted EPS
6.82
9.93
13.12
9.76
10.12
12.76
15.48
11.58
18.54
15.85
18.05
5.41

Dr Lal Pathlabs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
912.4
1,056.9
1,203.4
1,330.4
1,581.3
2,087.4
2,016.9
2,226.6
2,461.4
Other Income
27.5
31.2
46
55
51.3
52.5
41.7
69.2
93.4
Total Income
939.9
1,088.1
1,249.4
1,385.4
1,632.6
2,139.9
2,058.6
2,295.8
2,554.8
Expenses
674.9
792.9
909.8
986.8
1,145
1,526.7
1,527
1,617.3
1,765.9
Operating Profit
237.5
264
293.6
343.6
436.3
560.7
489.9
609.3
695.5
Operating Profit Margin %
26.03%
24.98%
24.4%
25.83%
27.59%
26.86%
24.29%
27.36%
28.26%
Profit Before Interest, Tax and Depreciation
265
295.2
339.6
398.6
487.6
613.2
531.6
678.5
788.9
Interest
0.7
0.8
0.8
15.3
16
30.2
37.5
29.4
22.3
Depreciation
27.6
33.1
38.2
72.8
77.2
108.1
150.2
143.6
141.9
Profit Before Tax
236.7
261.3
300.6
310.5
394.4
474.9
343.9
505.5
624.7
Tax Paid
81.2
89.6
100.1
82.9
97.9
124.6
102.8
143.2
132.5
Profit After Tax
155.5
171.7
200.5
227.6
296.5
350.3
241.1
362.3
492.2
Total Net profit including share of profit / Loss from associate company
155.5
171.7
200.5
227.6
296.5
350.3
241.1
362.3
492.2
EPS
18.92
20.85
24.19
27.42
35.33
41.7
28.82
43.05
58.48
Actual EPS
18.92
20.85
24.19
27.42
35.33
41.7
28.82
43.05
58.48
Adjusted EPS
9.46
10.43
12.1
13.71
17.67
20.85
14.41
21.53
29.24
Diluted EPS
18.85
20.82
24.15
27.37
33.25
41.57
28.74
42.98
58.4

Dr Lal Pathlabs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
158.54
171.31
197.07
218.54
283.89
398.15
446.69
456.03
535.33
568.89
Cash Flow from Investing Activities
-163.49
-137.09
-172.27
-99.74
-26.11
-212.01
-449.23
-287.31
-24.26
-303.16
Cash Flow from Financing Activities
0.36
-32.26
12.53
-55.26
-190.44
-138.55
136.45
-283.04
-413.87
-334.04
Net Cash Flow
-4.59
1.94
37.3
63.54
67.33
47.58
133.9
-114.46
97.2
-68.31

Dr Lal Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
55.01%
54.61%
54.6%
54.6%
54.6%
53.92%
53.91%
53.91%
53.79%
53.22%
53.22%
DII
7.33%
7.97%
8.61%
9.69%
12.71%
12.89%
13.17%
16.08%
17.91%
18.49%
19.21%
FII
0%
0%
0%
26.15%
25.42%
26.82%
26.82%
23.91%
21.68%
21.86%
20.29%
Government
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.01%
Public
12.66%
11.48%
10.12%
9.24%
6.96%
6.04%
5.82%
5.84%
6.23%
6.07%
6.94%
Total Outstanding Shares
8,34,08,877
8,34,69,852
8,34,77,852
8,34,77,852
8,34,80,352
8,35,74,252
8,35,87,735
8,35,91,735
8,37,75,510
8,37,75,510
16,75,51,020
Total Shareholders
1,74,444
1,60,679
1,49,901
1,46,741
1,31,189
1,16,606
1,16,236
1,15,699
1,18,656
1,12,703
1,16,167

Mutual Funds that own Dr Lal Stock

Check out the Mutual Funds with significant holdings in Dr Lal.

Dr Lal Corporate Actions

View detailed summary of the earnings and dividend history of Dr Lal.

  • Dr Lal Pathlabs Ltd Earnings Results

    Dr Lal Pathlabs Ltd’s net profit fell -6.41% since last year same period to ₹90.50Cr in the Q3 2025-2026. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated -39.91% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Dr Lal Pathlabs Ltd Dividends January,2026

    In the quarter ending December 2025, Dr Lal Pathlabs Ltd has declared dividend of ₹3.50 per share on 30 Jan 2026 - translating a dividend yield of 2.13%.

    Read More about Dividends

Indices Featuring Dr Lal Stock

Check stock indices that include Dr Lal.

S&P BSE SmallCap Select

₹7,498.19

-0.43 (32.65%)

Nifty Smallcap 50

₹8,091.85

-0.58 (47.15%)

BSE 500

₹35,232.05

-0.98 (346.98%)

BSE Healthcare

₹43,557.88

-0.27 (116.17%)

Nifty Smallcap 250

₹15,422.20

-0.28 (43.55%)

Nifty Small 100

₹16,498.90

-0.24 (39.90%)

Nifty 500

₹22,481.30

-0.95 (216.50%)

S&P BSE 250 SmallCap

₹6,104.32

-0.22 (13.64%)

Nifty MidSmallcap 400

₹19,039.90

-0.54 (104.15%)

S&P BSE 400 MidSmallCap

₹11,349.61

-0.53 (60.08%)

Insights on Dr Lal Pathlabs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 6.07% to 6.94% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 15.90% to 16.84% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Fortis Healthcare Ltd has given 228.0% return, outperforming this stock by 191.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Fortis Healthcare Ltd has given 42.0% return, outperforming this stock by 35.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 53.22% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 21.86% to 20.29% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 150.6 Cr → 90.5 Cr (in ₹), with an average decrease of 39.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, LALPATHLAB stock has moved down by -4.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 755.4 Cr → 684.2 Cr (in ₹), with an average decrease of 9.4% per quarter

About Dr Lal Pathlabs Ltd

Dr Lal PathLabs Ltd is a leading diagnostic laboratory chain in India, incorporated in 1949. The company operates in the medical diagnostics business and provides a wide range of services and products, including clinical laboratory services, radiology services, and preventive health check-up packages.

The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.

Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).

Revenue: ₹659.80Cr as on December 2025 (Q3 FY26)
Net Profit: ₹91.40Cr as on December 2025 (Q3 FY26)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
OrganisationDr Lal Pathlabs Ltd
HeadquartersGurgaon
IndustryHealthcare
CEOArvind Lal
E-voting on sharesClick here to vote

FAQs

What is Dr Lal share price today?

Dr Lal share price today stands at ₹1360 as on at the close of the market. Dr Lal share today touched a day high of ₹1366.9 and a low of ₹1332.5.

What is the 52 week high and 52 week low range for Dr Lal share?

Dr Lal touched a 52 week high of ₹1770 and a 52 week low of ₹1155.38. Dr Lal share price today i.e. is closed at ₹1360, which is -23.16% down from its 52 week high and 17.71% up from its 52 week low.

What is Dr Lal's market capitalisation today?

Dr Lal market capitalisation is ₹22,438.97 Cr as on .

How to buy Dr Lal shares?

To buy Dr Lal shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for LALPATHLAB or Dr Lal Pathlabs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Dr Lal shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Dr Lal trading volume today?

Dr Lal trading volume is 2.73L as on . This means that 2.73L shares of Dr Lal were bought and sold on the stock market during today's trading session.